Associations of urinary ACR with each 1-SD increase in FPG, 2 h PG and HbA1c
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| Variables | β±SE | p Value | β±SE | p Value | β±SE | p Value |
| FPG* | 0.090±0.008 | <0.0001 | 0.049±0.009 | <0.0001 | −0.003±0.014 | 0.84 |
| 2 h PG* | 0.106±0.008 | <0.0001 | 0.040±0.010 | <0.0001 | −0.008±0.013 | 0.54 |
| HbA1c** | 0.110±0.008 | <0.0001 | 0.067±0.009 | <0.0001 | 0.072±0.014 | <0.0001 |
Model 1: Unadjusted.
Model 2: Adjusted for age, sex, smoking and drinking status, physical activity, BMI, TG, HDL-c, LDL-c, SBP, use of ACEI/ARB drugs, use of antidiabetic drugs and eGFR.
Model 3: *Further adjusted for HbA1c based on model 2; **further adjusted for FPG and 2 h PG based on model 2.
β, regression coefficient; 2 h PG, 2 h postload glucose; ACEI, ACE inhibitor; ACR, albumin-to-creatinine ratio; ARB, angiotensin receptor blocker; BMI, body mass index; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HbA1c, glycated haemoglobin A1c; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TG, triglyceride.